Oncorus raises $79.5M series B with eye on global development

Nearly half a dozen Korean investment groups joined Oncorus' $79.5 million series B round as part of the company's long-range plan to take its oncolytic virus technology global.

Cowen Healthcare Investments and Perceptive Advisors led the round, which included fellow new investors Surveyor Capital, Sphera Funds and five Korean firms: Shinhan Investment-Private Equity, UTC

Read the full 546 word article

How to gain access

Continue reading with a
two-week free trial.